Habits: Clinical Trials

4 trials for Habits, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Withdrawn 1
Phase 22Completed 2

Follow Habits: new trials by email Literature Review of Habits trials Research Report on Habits

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Management of Bruxism in Patients With Implant Overdenture
Botulinium toxin type A injection, Maxillary Occlusal Stabilization Splint - Bruxism
Phase 1CompletedDelta University for Science and Technology482024-03-242026-01-23
Botox for Treatment of TMJ Disorder With Bruxism
onabotulinumtoxinA - Temporomandibular Joint Disorders, Bruxism
Phase 1WithdrawnWashington University School of Medicine2015-01-012018-01-23
Occlusal Adjustment as Treatment for Chronic Orofacial Pain
Occlusal adjustment, Placebo occlusal adjustment - Temporomandibular Joint Disorders, Orofacial Pain
Phase 1 / Phase 2CompletedUniversity of Santiago de Compostela212009-05-012013-07-26
Antibody and Safety Study of 6 Doses of NicVAX in Smokers
3'-aminomethyl-Nic r-EPA Conjugate (NicVAX®) - Smoking
Phase 1 / Phase 2CompletedNabi Biopharmaceuticals742008-01-012012-05-09

Narrower conditions

Bruxism (3)  ·  Temporomandibular Joint Disorders (2)  ·  Temporomandibular Joint Dysfunction Syndrome (2)  ·  Facial Pain (1)  ·  Pain (1)  ·  Smoking (1)

Broader conditions

Behavior (4)  ·  Stomatognathic Diseases (3)  ·  Tooth Diseases (3)  ·  Craniomandibular Disorders (2)  ·  Jaw Diseases (2)  ·  Joint Diseases (2)  ·  Mandibular Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Myofascial Pain Syndromes (2)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Botulinum Toxins, Type A (2)  ·  NicVAX (1)  ·  Occlusal Adjustment (1)

Sponsors

Delta University for Science and Technology (1)  ·  Nabi Biopharmaceuticals (1)  ·  University of Santiago de Compostela (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  Egypt (1)  ·  Spain (1)

Top investigators

Alan A Harvey, DMD (1)  ·  Matt Hohenboken, MD, PhD (1)  ·  Wafaa I Ibrahim, Assoc. Prof. (1)

Results publications

PMID 21270788, PMID 22229310